Evidence map›Paper›PMID 30844383›Full record

ReviewProgress in cardiovascular diseases

A role for FNDC5/Irisin in the beneficial effects of exercise on the brain and in neurodegenerative diseases.

Michael F Young, Sophia Valaris, Christiane D Wrann

Abstract readReview
In one paragraph

Review in Progress in cardiovascular diseases. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 67 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
67citing papers in PubMed, 2 pooled it
9.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

67 citing papers in PubMed, 2 syntheses or guidelines pooled it, 130 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Irisin Restrains Oligodendroglial Ferroptosis to Preserve White Matter After Traumatic Brain Injury via AMPK Activation.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Observational
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review

7 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Michael F YoungMassachusetts General Hospital, Harvard Medical School, Boston, United States of America.
Sophia ValarisMassachusetts General Hospital, Harvard Medical School, Boston, United States of America.
Christiane D WrannMassachusetts General Hospital, Harvard Medical School, Boston, United States of America; Broad Institute of MIT and Harvard, Cambridge, Boston, United States of America; Harvard Stem Cell Institute, Cambridge, MA, United States of America; Henry and Allison McCance Center for Brain Health, Massachusetts General Hospital, Boston, MA, United States of America. Electronic address: cwrann@mgh.harvard.edu.
Broad Institute · USHarvard University · USMassachusetts General Hospital · US

Funding

Molecular mechanisms of exercise benefits in synapse plasticity and cognitionR00NS087096 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI WRANN, CHRISTIANE D. · 2017 to 2019
$745k
NINDS NIH HHS R00 NS087096
6 · The paper itself

Abstract

The beneficial effects of exercise on the brain are well known. However, the underlying molecular mechanisms are much less well understood. Interestingly, myokines, hormones secreted by muscle in response to exercise, gained attention as such beneficial mediators. In this review, we will focus on FNDC5 and its secreted form, the newly discovered myokine "irisin". We will discuss their role in the beneficial effects of exercise and its potential application in neurodegenerative disorders.

Indexed as

FibronectinsNeurodegenerative DiseasesBrainCognitionExerciseHumansMuscle, SkeletalNeuroprotectionFibronectinsFNDC5 protein, humanCognitionExerciseFNDC5HippocampusIrisinNeurodegenerationPhysical activity

Identifiers

PMID30844383
PMCPMC6955153
OpenAlexW2919998750

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.